SOD2-Superoxide dismutase

Added to your cart

SOD2-Superoxide dismutase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU SOD2

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Superoxide dismutase is an enzyme which converts O2- radicals into either O2 or H2O2. It has powerful anti-inflammatory activity and has been used to research treatments for inflammatory disorders and free radical damage to the skin.
SOD2

More information

Attributes

Description

  • Abbreviations
  • SOD2
  • Associated Activity
  • Carbonic anhydrase: less than 0.01%
  • Lead Time
  • 8 weeks
  • Storage
  • Store desiccated at -15C or below. Allow to come
  • Shelf Life
  • 3 years
  • Source
  • Bovine erythrocytes
  • Activity
  • ≥3000U/mg material (approximately 3500 U/mg protein)
  • EC Number
  • 1.15.1.1
  • Solubility
  • Dissolves readily at 5mg/ml in 0.05M Potassium phosphate buffer, pH 7.8, containing 0.1mM EDTA, to give a clear solution.
  • Systematic Name
  • Superoxide:superoxide oxidoreductase
  • Unit Definition
  • That amount of enzyme causing a 50% inhibition in the rate of reduction of Cytochrome C under the conditions of assay.

Technical Documents

Product Specification (56.32KB)

Analytical Procedures (155.65KB)

Product Information (195.81KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox